HealthCor Management as of Dec. 31, 2013
Portfolio Holdings for HealthCor Management
HealthCor Management holds 46 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Allscripts Healthcare Solutions (MDRX) | 9.4 | $155M | 10M | 15.46 | |
| McKesson Corporation (MCK) | 5.9 | $97M | 600k | 161.40 | |
| Cubist Pharmaceuticals | 5.9 | $96M | 1.4M | 68.87 | |
| ArthroCare Corporation | 5.8 | $96M | 2.4M | 40.24 | |
| Wright Medical | 5.7 | $94M | 3.1M | 30.71 | |
| Allergan | 5.6 | $92M | 825k | 111.08 | |
| eHealth (EHTH) | 4.8 | $79M | 1.7M | 46.49 | |
| Aegerion Pharmaceuticals | 3.7 | $60M | 850k | 70.96 | |
| Alexion Pharmaceuticals | 3.6 | $60M | 450k | 132.88 | |
| Mead Johnson Nutrition | 3.0 | $50M | 600k | 83.76 | |
| Teva Pharmaceutical Industries (TEVA) | 2.8 | $47M | 1.2M | 40.08 | |
| WebMD Health | 2.8 | $45M | 1.2M | 39.50 | |
| Mylan | 2.7 | $45M | 1.0M | 43.40 | |
| Molina Healthcare (MOH) | 2.7 | $44M | 1.3M | 34.75 | |
| Abbott Laboratories (ABT) | 2.6 | $43M | 1.1M | 38.33 | |
| Dynavax Technologies Corporation | 2.4 | $39M | 20M | 1.96 | |
| Whitewave Foods | 2.3 | $38M | 1.7M | 22.94 | |
| Salix Pharmaceuticals | 2.2 | $36M | 400k | 89.94 | |
| Agilent Technologies Inc C ommon (A) | 2.2 | $36M | 625k | 57.19 | |
| Beam | 2.1 | $34M | 500k | 68.06 | |
| Relypsa | 1.7 | $28M | 1.1M | 25.00 | |
| Estee Lauder Companies (EL) | 1.6 | $26M | 350k | 75.32 | |
| Theravance | 1.6 | $26M | 725k | 35.65 | |
| Tenet Healthcare Corporation (THC) | 1.5 | $25M | 600k | 42.12 | |
| NuVasive | 1.5 | $25M | 775k | 32.33 | |
| Novavax | 1.4 | $24M | 4.6M | 5.12 | |
| Five Prime Therapeutics | 1.2 | $20M | 1.2M | 16.79 | |
| Cynosure | 1.2 | $20M | 750k | 26.64 | |
| Intuitive Surgical (ISRG) | 1.2 | $19M | 51k | 384.07 | |
| Exelixis (EXEL) | 1.1 | $19M | 3.1M | 6.13 | |
| Idera Pharmaceuticals | 0.9 | $16M | 3.4M | 4.63 | |
| Shire | 0.9 | $14M | 100k | 141.29 | |
| Myriad Genetics (MYGN) | 0.8 | $14M | 650k | 20.98 | |
| Gilead Sciences (GILD) | 0.8 | $13M | 175k | 75.10 | |
| Regulus Therapeutics | 0.8 | $13M | 1.8M | 7.39 | |
| Acorda Therapeutics | 0.7 | $12M | 400k | 29.20 | |
| Biogen Idec (BIIB) | 0.5 | $7.8M | 28k | 279.57 | |
| Monsanto Company | 0.5 | $7.4M | 63k | 116.55 | |
| Clovis Oncology | 0.4 | $5.9M | 99k | 60.27 | |
| Merck & Co (MRK) | 0.3 | $5.7M | 114k | 50.05 | |
| Hca Holdings (HCA) | 0.3 | $5.1M | 107k | 47.71 | |
| Zimmer Holdings (ZBH) | 0.3 | $4.7M | 51k | 93.20 | |
| Actavis | 0.3 | $4.5M | 27k | 167.99 | |
| Thermo Fisher Scientific (TMO) | 0.2 | $3.0M | 27k | 111.36 | |
| Health Management Associates | 0.2 | $2.6M | 200k | 13.10 | |
| Cardiovascular Systems | 0.1 | $1.7M | 50k | 34.30 |
